Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Mini Review
Idiopathic Pulmonary Fibrosis: Emerging Therapies and Patient Outcomes
Author(s): Denial Aster*
Idiopathic Pulmonary Fibrosis (IPF) is a progressive and debilitating lung disease characterized by the gradual scarring of lung tissue, leading
to impaired respiratory function and poor prognosis. Despite its challenging nature, recent years have witnessed significant advancements in
the understanding and management of IPF, with the emergence of novel therapies aimed at slowing disease progression and improving patient
outcomes. This article explores the latest developments in IPF treatment, including the mechanisms of action of emerging therapies, clinical trial
results and their impact on patient survival and quality of life. By examining the evolving landscape of IPF management, we gain insights into the
potential of these innovative treatments to transform the lives of individuals living with this devastating disease... Read More»
DOI:
10.37421/2472-1018.2024.10.243
Journal of Lung Diseases & Treatment received 247 citations as per Google Scholar report